BioMarin Pharmaceutical Inc. · 2 weeks ago
Project Manager 2, Research
BioMarin Pharmaceutical Inc. is a global biotechnology company that pursues bold science to translate genetic discoveries into new medicines. The Research Project Manager 2 plays a critical role in supporting early-stage research programs, partnering with various leads and stakeholders to drive operational and strategic direction across a portfolio of projects.
BiotechnologyDeveloper PlatformPharmaceutical
Responsibilities
Act as a strategic thought partner to TA Leads and PTLs, supporting high-performing teams and alignment with program strategy
Partner with the Research PTLs and TA Leads in driving the operational and strategic direction of TA portfolio of projects to meet RED TA corporate goals and objectives
Partner in shaping and maintaining TA-owned program plans, strategic deliverables, Objectives and Key Results (OKRs)
Create a comprehensive project timeline at kick-off, incorporating the current strategy, key anticipated milestones, and deliverables to guide execution and alignment
Lead Research fiscal AOP and reforecasting planning by collecting and capturing program team requirements
Liaise with PTLs, functional managers, and TA Leads to capture and analyze FTE requirements for planned deliverables and priorities
Identify, communicate, and support mitigation strategies for any potential or known project risks to TA heads, PTLs, and relevant stakeholders
Drive progress toward program and department goals by actively tracking deliverables and holding teams accountable for timely action item completion
Prepare agendas, minutes, and supporting materials for team meetings; may drive Lessons Learned sessions after major milestones
Maintain accurate, real-time timelines with clear milestones, deliverables, and assumptions to ensure transparency and support downstream reporting across departments
Create and maintain monthly executive dashboards and governance materials for clear reporting and decision-making
Maintain stage criteria and dates during the Exploratory phase through projected IND
Drive fiscal planning and budget compliance through AOP build, reforecasts, and real-time updates; maintain oversight of scope changes, mitigating variance, and providing trade-off solutions or escalating as needed
Support change management efforts in Research, RED PM group, the PMO, or other collaborative stakeholders such as PPS
Proactively manage and escalate emerging risks, interdependencies, and decision needs before they impact execution
Manage and maintain team folder infrastructure and collaboration sites (MS Teams, SharePoint), ensuring key documents and dashboards are current, aligned, and readily accessible for communication
Provide guidance, preparation, facilitation, and documentation for all governance (eRRC, RRC), ensuring timely discussions on strategy, emerging data, budget and resourcing, ensuring all relevant stakeholders are present
Support Scientific Portfolio Review (SPR) by coordinating templates, timelines, and partnering with PPS for dashboards. Act as point of contact for communications between TAs and cross-functional teams or external stakeholders
Qualification
Required
Master of Science, or minimally Bachelor of Science degree
4 - 8 years' total relevant experience in drug development (academia/research/industry), with a minimum of 3 years direct project management in Research and/or early-stage drug development
Preferred
Ph.D. in Life Sciences or other relevant discipline
PMP or comparable certification
Company
BioMarin Pharmaceutical Inc.
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery.
H1B Sponsorship
BioMarin Pharmaceutical Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (34)
2024 (23)
2023 (24)
2022 (26)
2021 (24)
2020 (19)
Funding
Current Stage
Public CompanyTotal Funding
$585.8M2020-05-11Post Ipo Debt· $585.8M
1999-07-26IPO
Recent News
Morningstar.com
2026-01-09
Company data provided by crunchbase